The improvement in OS in the ITT analysis did not reach statistical significance so as per protocol the OS analysis could not be tested in the PD-L1-positive group.
← all excerpts
Optimal Choice of Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer: Clinical Insights.
1
—
—